ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/05/2026
Back to search
Official data from USPTO
ANALGESINA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ANALGESINA
ST13
US500000079290423Class
1, 5
Filing
79290423
Registration
6465668
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/06/2026
Trademark type
Word
Nice classes
1, 5
Filing date
04/28/2020
Registration date
08/31/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/31/2021
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
IT
Examiner
ELTON, DAVID JONATHAN
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CRISTALFARMA S.r.l.
Representatives
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Plant and herb extracts for use in the manufacture of pharmaceuticals and phytotherapy preparations for medical purposes; chemical and organic compositionsnamely chemical additivesantioxidantsfor use in the manufacture of food and beverages
Class 5
Natural remedy preparations for use in the prophylaxis or treatment of migraine; phytotherapy preparations for medical purposes; migraine treatment preparations; food supplements; nutritional supplements; dietetic preparations adapted for medical use
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/18/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2022
FIMP
FINAL DISPOSITION PROCESSED
02/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/30/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/31/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/15/2021
PUBO
PUBLISHED FOR OPPOSITION
06/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/11/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/09/2021
GNFR
FINAL REFUSAL E-MAILED
04/09/2021
CNFR
FINAL REFUSAL WRITTEN
04/09/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2021
ALIE
ASSIGNED TO LIE
02/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/12/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/12/2020
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/07/2020
RFRR
REFUSAL PROCESSED BY MPU
09/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
08/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2020
CNRT
NON-FINAL ACTION WRITTEN
08/01/2020
DOCK
ASSIGNED TO EXAMINER
07/31/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/30/2020
Continuous trademark protection
Get notified about every new filing that threatens ANALGESINA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.